Proteomics International Laboratories Ltd (ASX:PIQ) US update - PromarkerD Licensing Negotiations

Proteomics International Laboratories Ltd (ASX:PIQ) advises that it is in the closing stages of finalising the detailed terms of its Exclusive Licence Agreement with Sonic Healthcare USA for use of the Company's PromarkerD predictive test for diabetic kidney disease in the United States.

Related Keywords

Perth , Western Australia , Australia , United States , Richard Lipscombe , Proteomics International Laboratories , Proteomics International , Company Promarker , Proteomics International Laboratories Ltd , International Laboratories Ltd , Exclusive Licence Agreement , Sonic Healthcare United States , International Laboratories , Print This , Page Viewed , Biotech , Health Pharm Generalproteomics International Laboratories Ltd , Asx Piq ,